Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

SB421: Pharmacist; remote verification and counseling in opioid treatment programs.

signed by governor

<b>Remote pharmacist verification and counseling in opioid treatment programs.</b> Authorizes a pharmacist licensed in the Commonwealth to exercise verification, counseling, and supervision duties remotely when a pharmacy technician or other authorized personnel dispenses medication prescribed for the management of opioid use disorder at a federally certified opioid treatment program.

Official bill page · Source: Richmond Sunlight

Ask about SB421

Full bill text

Version CHAP0345 · 2026-04-06 · Official source text

Full text

Changes in this version: added text deleted text

An Act to amend and reenact § 54.1-3432 of the Code of Virginia and to amend the Code of Virginia by adding a section numbered 54.1-3303.2, relating to remote pharmacist verification and counseling in opioid treatment programs.

Be it enacted by the General Assembly of Virginia:

1. That § 54.1-3432 of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered 54.1-3303.2 as follows:

§ 54.1-3303.2. Remote pharmacist verification and counseling in opioid treatment programs.

A. Notwithstanding any other provision of law, a pharmacist may remotely provide counseling for the dispensing of methadone or other medications prescribed for the management of opioid use disorder and provide remote supervision and verification of the accuracy of the dispensed drug in all aspects through real-time, two-way audiovisual communication during operating hours and in accordance with Board regulation at a federally certified opioid treatment program.

B. A pharmacy technician or other authorized personnel may dispense such medication pursuant to subsection A provided that:

1. The pharmacist is licensed and in good standing in the Commonwealth;

2. The pharmacist is immediately available through real-time audiovisual communication and able to provide visual supervision during operating hours of those persons performing the duties of a pharmacy technician;

3. The pharmacist performs all professional judgment functions required by law prior to dispensing; and

4. The opioid treatment program complies with all federal requirements.

C. The Board shall promulgate regulations establishing requirements for:

1. Technology standards of equipment used for remote verification, the provision of counseling, and visual supervision;

2. Training and competency of personnel;

3. Documentation and recordkeeping;

4. Patient privacy and safety; and

5. Pharmacists to serve as pharmacist-in-charge at multiple pharmacies operating within an opioid treatment program in accordance with this section, which may include a requirement for the pharmacist to be physically present on-site at least one day per calendar month.

D. Nothing in this section shall be construed to require an opioid treatment program to utilize remote pharmacist supervision or limit the authority of the Board to enforce standards of practice or take disciplinary action.

§ 54.1-3432. Supervision by pharmacist.

Every pharmacy shall be under the personal supervision of a pharmacist on the premises of the pharmacy except as provided in § 54.1-3303.2.

2. That the Board of Pharmacy shall promulgate regulations to implement the provisions of this act and such regulations shall be exempt from the requirements of the Administrative Process Act (§ 2.2-4000 et seq.) of the Code of Virginia.

Legislative actions

2026-03-04 · history

Fiscal Impact Statement from Department of Planning and Budget (SB421)

2026-02-06 · history

Passed by for the day

2026-02-24 · history

Reported from Health and Human Services (19-Y 3-N)

2026-01-30 · history

Assigned Education sub: Health Professions

2026-02-26 · history

Read second time

2026-02-05 · history

Reported from Education and Health

2026-02-05 · history

Reported from Education and Health (14-Y 0-N)

2026-01-13 · history

Prefiled and ordered printed; Offered 01-14-2026 26104861D

2026-02-06 · history

Constitutional reading dispensed Block Vote (on 1st reading) (39-Y 0-N 0-A)

2026-02-13 · history

Placed on Calendar

2026-04-06 · history

Approved by Governor-Chapter 345 (effective 7/1/2026)

2026-02-19 · history

Subcommittee recommends reporting

2026-02-13 · history

Read first time

2026-02-09 · history

Engrossed by Senate Block Vote (Voice Vote)

2026-02-19 · history

Subcommittee recommends reporting (10-Y 0-N)

2026-03-04 · history

Enrolled

2026-03-10 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

2026-03-04 · history

Signed by Speaker

2026-03-10 · history

Enrolled Bill communicated to Governor on March 10, 2026

2026-01-13 · history

Referred to Committee on Education and Health

2026-03-04 · history

Bill text as passed Senate and House (SB421ER)

2026-04-06 · history

Acts of Assembly Chapter text (CHAP0345)

2026-01-29 · history

Fiscal Impact Statement from Department of Planning and Budget (SB421)

2026-02-24 · history

Reported from Health and Human Services

2026-03-04 · history

Signed by President

2026-02-10 · history

Read third time and passed Senate Block Vote (40-Y 0-N 0-A)

2026-02-09 · history

Read second time

2026-02-13 · history

Referred to Committee on Health and Human Services

2026-02-13 · history

Read first time

2026-02-27 · history

Read third time

2026-02-27 · history

Passed House (91-Y 5-N 0-A)

2026-02-06 · history

Passed by for the day Block Vote (Voice Vote)

2026-02-16 · history

Assigned sub: Health Professions

2026-02-06 · history

Rules suspended

Raw source record
{
    "id": 85399,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/sb421\/",
    "tags": {
        "148398": "pharmacist",
        "148399": "opioid",
        "148400": "telehealth",
        "148401": "addiction",
        "148402": "counseling",
        "148403": "medicine",
        "148404": "pharmacy",
        "148405": "opioid treatment",
        "148406": "healthcare"
    },
    "text": [
        {
            "date": "2026-01-13",
            "number": "SB421",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/sb421.pdf"
        },
        {
            "date": "2026-03-04",
            "number": "SB421ER"
        },
        {
            "date": "2026-04-06",
            "number": "CHAP0345"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "sb421",
    "patron": "Favola, Barbara",
    "status": "signed by governor",
    "chamber": "senate",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 85905,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "hb1416",
            "status": "failed committee",
            "catch_line": "Influenza prophylaxis; pharmacists initiation of treatment.",
            "date_introduced": "January 22, 2026"
        },
        {
            "id": 85549,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb545",
            "status": "failed committee",
            "catch_line": "Ivermectin; authorize over-the-counter sale.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 85075,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb1172",
            "status": "failed committee",
            "catch_line": "Pharmacy freedom of choice; specialty pharmacy benefits.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 85396,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb418",
            "status": "signed by governor",
            "catch_line": "Therapeutic interchange; authorizes pharmacists to perform, adaptation of prescriptions.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 85357,
            "name": "Education and Health",
            "year": 2026,
            "count": 2,
            "number": "sb379",
            "status": "signed by governor",
            "catch_line": "Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.",
            "date_introduced": "January 13, 2026"
        }
    ],
    "summary": "<b>Remote pharmacist verification and counseling in opioid treatment programs.<\/b> Authorizes a pharmacist licensed in the Commonwealth to exercise verification, counseling, and supervision duties remotely when a pharmacy technician or other authorized personnel dispenses medication prescribed for the management of opioid use disorder at a federally certified opioid treatment program.",
    "version": "CHAP0345",
    "copatron": null,
    "committee": "Education and Health",
    "full_text": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3432\/'>54.1-3432<\/a> of the Code of Virginia and to amend the Code of Virginia by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a>, relating to remote pharmacist verification and counseling in opioid treatment programs.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3432\/'>54.1-3432<\/a> of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a>. Remote pharmacist verification and counseling in opioid treatment programs.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. Notwithstanding any other provision of law, a pharmacist may remotely provide counseling for the dispensing of methadone or other medications prescribed for the management of opioid use disorder and provide remote supervision and verification of the accuracy of the dispensed drug in all aspects through real-time, two-way audiovisual communication during operating hours and in accordance with Board regulation at a federally certified opioid treatment program.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. A pharmacy technician or other authorized personnel may dispense such medication pursuant to subsection A provided that:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. The pharmacist is licensed and in good standing in the Commonwealth;<\/ins><\/p><p class=\"section\"><em class=\"new\">2. The pharmacist is immediately available through real-time audiovisual communication and able to provide visual supervision during operating hours of those persons performing the duties of a pharmacy technician;<\/ins><\/p><p class=\"section\"><em class=\"new\">3. The pharmacist performs all professional judgment functions required by law prior to dispensing; and<\/ins><\/p><p class=\"section\"><em class=\"new\">4. The opioid treatment program complies with all federal requirements.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. The Board shall promulgate regulations establishing requirements for:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. Technology standards of equipment used for remote verification, the provision of counseling, and visual supervision;<\/ins><\/p><p class=\"section\"><em class=\"new\">2. Training and competency of personnel;<\/ins><\/p><p class=\"section\"><em class=\"new\">3. Documentation and recordkeeping;<\/ins><\/p><p class=\"section\"><em class=\"new\">4. Patient privacy and safety; and<\/ins><\/p><p class=\"section\"><em class=\"new\">5. Pharmacists to serve as pharmacist-in-charge at multiple pharmacies operating within an opioid treatment program in accordance with this section<s>,<\/s> which may include a requirement for the pharmacist to be physically present on-site at least one day per calendar month.<\/ins><\/p><p class=\"section\"><em class=\"new\">D. Nothing in this section shall be construed to require an opioid treatment program to utilize remote pharmacist supervision or limit the authority of the Board to enforce standards of practice or take disciplinary action.<\/ins><\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3432\/'>54.1-3432<\/a>. Supervision by pharmacist.<\/p><p class=\"section\">Every pharmacy shall be under the personal supervision of a pharmacist on the premises of the pharmacy<em class=\"new\"> except as provided in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a><\/ins>.<\/p><p class=\"enactcls\">2. That the Board of Pharmacy shall promulgate regulations to implement the provisions of this act and such regulations shall be exempt from the requirements of the Administrative Process Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/2.2-4000\/'>2.2-4000<\/a> et seq.) of the Code of Virginia.<\/p>",
    "catch_line": "Pharmacist; remote verification and counseling in opioid treatment programs.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 633,
    "patron_party": "D",
    "patron_place": "Arlington",
    "summary_hash": "4d761593133499afc9e3f577aa226d0a",
    "patron_prefix": "Sen.",
    "patron_suffix": "(D-Arlington)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "b9eda236a87ecd138e102e82f5fabca09b36a51af6c465f111bedaa7fdc2edcc",
            "code": "CHAP0345",
            "bill_id": 85399,
            "source_url": null,
            "source_date": "2026-04-06",
            "source_hash": "f1691b7ec0b76287536b774a6147290e14e16626ebab2e786944470e15142288",
            "source_html": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3432\/'>54.1-3432<\/a> of the Code of Virginia and to amend the Code of Virginia by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a>, relating to remote pharmacist verification and counseling in opioid treatment programs.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3432\/'>54.1-3432<\/a> of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a>. Remote pharmacist verification and counseling in opioid treatment programs.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. Notwithstanding any other provision of law, a pharmacist may remotely provide counseling for the dispensing of methadone or other medications prescribed for the management of opioid use disorder and provide remote supervision and verification of the accuracy of the dispensed drug in all aspects through real-time, two-way audiovisual communication during operating hours and in accordance with Board regulation at a federally certified opioid treatment program.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. A pharmacy technician or other authorized personnel may dispense such medication pursuant to subsection A provided that:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. The pharmacist is licensed and in good standing in the Commonwealth;<\/ins><\/p><p class=\"section\"><em class=\"new\">2. The pharmacist is immediately available through real-time audiovisual communication and able to provide visual supervision during operating hours of those persons performing the duties of a pharmacy technician;<\/ins><\/p><p class=\"section\"><em class=\"new\">3. The pharmacist performs all professional judgment functions required by law prior to dispensing; and<\/ins><\/p><p class=\"section\"><em class=\"new\">4. The opioid treatment program complies with all federal requirements.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. The Board shall promulgate regulations establishing requirements for:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. Technology standards of equipment used for remote verification, the provision of counseling, and visual supervision;<\/ins><\/p><p class=\"section\"><em class=\"new\">2. Training and competency of personnel;<\/ins><\/p><p class=\"section\"><em class=\"new\">3. Documentation and recordkeeping;<\/ins><\/p><p class=\"section\"><em class=\"new\">4. Patient privacy and safety; and<\/ins><\/p><p class=\"section\"><em class=\"new\">5. Pharmacists to serve as pharmacist-in-charge at multiple pharmacies operating within an opioid treatment program in accordance with this section<s>,<\/s> which may include a requirement for the pharmacist to be physically present on-site at least one day per calendar month.<\/ins><\/p><p class=\"section\"><em class=\"new\">D. Nothing in this section shall be construed to require an opioid treatment program to utilize remote pharmacist supervision or limit the authority of the Board to enforce standards of practice or take disciplinary action.<\/ins><\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3432\/'>54.1-3432<\/a>. Supervision by pharmacist.<\/p><p class=\"section\">Every pharmacy shall be under the personal supervision of a pharmacist on the premises of the pharmacy<em class=\"new\"> except as provided in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3303.2\/'>54.1-3303.2<\/a><\/ins>.<\/p><p class=\"enactcls\">2. That the Board of Pharmacy shall promulgate regulations to implement the provisions of this act and such regulations shall be exempt from the requirements of the Administrative Process Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/2.2-4000\/'>2.2-4000<\/a> et seq.) of the Code of Virginia.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-04-06",
                    "number": "CHAP0345"
                }
            }
        }
    ],
    "copatron_count": 0,
    "patron_address": [
        "P.O. Box 687",
        "Arlington",
        "VA 22216"
    ],
    "patron_chamber": "senate",
    "patron_started": 2012,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "04\/06\/2026",
            "status": "Acts of Assembly Chapter text (CHAP0345)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/06\/2026",
            "status": "Approved by Governor-Chapter 345 (effective 7\/1\/2026)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "03\/10\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Enrolled Bill communicated to Governor on March 10, 2026",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/04\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (SB421)",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Bill text as passed Senate and House (SB421ER)",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "Passed House (91-Y 5-N 0-A)",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": "299537",
            "translation": "passed house"
        },
        {
            "date": "02\/27\/2026",
            "status": "Read third time",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/26\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-26",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/24\/2026",
            "status": "Reported from Health and Human Services (19-Y 3-N)",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": "298611",
            "translation": "passed committee"
        },
        {
            "date": "02\/24\/2026",
            "status": "Reported from Health and Human Services",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": "298611",
            "translation": "passed committee"
        },
        {
            "date": "02\/19\/2026",
            "status": "Subcommittee recommends reporting (10-Y 0-N)",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": "298174",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/19\/2026",
            "status": "Subcommittee recommends reporting",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": "298174",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/16\/2026",
            "status": "Assigned sub: Health Professions",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/13\/2026",
            "status": "Referred to Committee on Health and Human Services",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/13\/2026",
            "status": "Placed on Calendar",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/10\/2026",
            "status": "Read third time and passed Senate  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": "295863",
            "translation": "passed senate"
        },
        {
            "date": "02\/09\/2026",
            "status": "Engrossed by Senate  Block Vote (Voice Vote)",
            "date_raw": "2026-02-09",
            "vote_count": null,
            "lis_vote_id": "295500",
            "translation": null
        },
        {
            "date": "02\/09\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/06\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-02-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/06\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-02-06",
            "vote_count": null,
            "lis_vote_id": "295242",
            "translation": null
        },
        {
            "date": "02\/06\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 1st reading) (39-Y 0-N 0-A)",
            "date_raw": "2026-02-06",
            "vote_count": null,
            "lis_vote_id": "295241",
            "translation": null
        },
        {
            "date": "02\/06\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-02-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Education and Health (14-Y 0-N)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": "294713",
            "translation": "passed committee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Education and Health",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "01\/30\/2026",
            "status": "Assigned Education sub: Health Professions",
            "date_raw": "2026-01-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/29\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (SB421)",
            "date_raw": "2026-01-29",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/13\/2026",
            "status": "Referred to Committee on Education and Health",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26104861D",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 376,
    "date_introduced": "2026-01-13",
    "patron_district": 40,
    "patron_shortname": "bafavola",
    "committee_chamber": "senate",
    "status_detail_date": "04\/06\/2026",
    "committee_shortname": "education",
    "patron_name_formatted": "Sen. Barbara Favola (D-Arlington)"
}